How Often Do You Use Mounjaro — and What Happens Between Doses?

Step 1, the first four weeks: one injection, 2.5 mg, once a week

The starting dose is 2.5 mg, and it is not there to produce rapid weight loss. Its job is to let your system adjust to the medicine, the GI side effects that some people notice at higher doses are far less common at this level. You inject once, then wait a full seven days before the next one. Most people pick a day that fits their week, say a Sunday evening or a Tuesday morning, and stick to it. The pen itself holds four doses, so one KwikPen covers the entire first month.

A question our prescribers hear most weeks is whether the first pen is 'doing anything', the honest answer is that 2.5 mg is settling your system, not yet driving meaningful weight reduction. That comes later. Trying to hurry past this stage by injecting more often is both ineffective and unsafe; the dose schedule in the licensed SmPC exists for a reason. You can read the full prescribing detail on the Mounjaro SmPC on the eMC.

If you want a broader introduction to what tirzepatide is and how it works as a dual GIP and GLP-1 receptor agonist, the tirzepatide overview covers the mechanism clearly.

Step 2 (four-weekly titration: the dose goes up, the frequency stays the same

After the first four weeks on 2.5 mg, the prescriber typically steps you to 5 mg) still once a week. Then 7.5 mg after another four weeks, and so on up through 10 mg, 12.5 mg, and a maximum of 15 mg. At every single stage, the dosing frequency is once weekly. That fact does not change regardless of which strength you are on.

The titration pace can slow if side effects are uncomfortable. Spending longer at a given dose before moving up is a clinical decision, not a failure. What does not change is the once-weekly injection. Taking an extra dose mid-week to compensate for a difficult week, or skipping a week to 'reset', are both off-script and potentially unsafe. More detail on the general question of how often you take Mounjaro across the whole titration journey is worth reading alongside this page.

Mounjaro is licensed for adults with a BMI of 30 or above, or 27 or above alongside a weight-related health condition such as high blood pressure, dyslipidaemia or type 2 diabetes. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. BMI alone does not guarantee suitability, a prescriber reviews the full picture.

Step 3 (maintenance: same day, every week, ongoing

Once you reach the highest dose your prescriber has approved) which may or may not be the maximum 15 mg, the pattern becomes maintenance: one injection, once a week, indefinitely for as long as treatment continues and is clinically appropriate. There is no tapering-off phase built into the schedule the way there is for some other medicines.

Consistency of timing matters here. Injecting on the same day each week keeps plasma levels of tirzepatide stable; drifting by several days in either direction risks a less smooth effect. If you want to shift your injection day, say from Saturday to Wednesday, it is possible to do gradually over a few weeks rather than jumping, and your prescriber or the Patient Information Leaflet can guide the specifics.

For context on what private treatment costs and how pricing is structured across the dose schedule, the Mounjaro pricing page lays that out plainly. It is worth knowing before you start that higher doses do not mean more frequent injections, just a different pen strength.

What affects how you use each pen

The KwikPen delivers four consecutive once-weekly doses, so each pen lasts one month. Injection sites rotate between the abdomen, thigh and upper arm, using the same spot every week can cause localised skin changes over time. Storage is in the fridge at 2–8°C; there is a limited window during which a pen can be kept at room temperature, and the exact duration is specified in the Patient Information Leaflet rather than here, because that is the authoritative source.

The full guide to using a Mounjaro pen covers technique, site rotation and storage in more detail. For the closely related question of tirzepatide frequency across different clinical situations, how often you can take tirzepatide addresses some of the edge cases that come up. Common side effects (nausea, constipation, indigestion) are most noticeable after starting or stepping up, and tend to settle within the first week or two at each new dose level, as the Mounjaro treatment page explains.

Mounjaro carries a Black Triangle (▼) designation, meaning it is subject to additional MHRA monitoring while post-authorisation safety data builds. This is routine for newer medicines and does not indicate an unusual risk profile, it means any new safety information is reviewed quickly. Patients can report any suspected side effects through the MHRA Yellow Card scheme.

If you are ready to talk through your own situation with a prescriber, you can start a free consultation with our prescribers today, they review every assessment personally, the same day.